Monopar Therapeutics Inc.MNPRNASDAQ
Loading
Cash Flow PerformanceElevated
Percentile Rank33
Studio
Year-over-Year Change

Free cash flow yield

Latest
-2.54%
↑ 44% vs avg
Percentile
P33
Within normal range
Streak
1 yr
Consecutive growthElevated
Average
-4.51%
Historical baseline
PeriodValueYoY Change
2024-2.54%+92.0%
2023-31.86%-564.2%
2022-4.80%-31.2%
2021-3.66%-162.9%
2020-1.39%-304.9%
2019-0.34%-64.2%
2018-0.21%-9.9%
2017-0.19%-108.0%
2016-0.09%-55.4%
2015-0.06%-